HOME >> BIOLOGY >> NEWS
Welch Award honors McConnell for insights into physical chemistry, cell membranes

ear magnetic resonance (NMR) data to the structure of molecules. He modified the equations governing NMR to include the effects of chemical reactions, and used the results to measure chemical kinetics, i.e., the speed at which reactions take place. He has also pioneered research on free radicals an extremely reactive type of chemical that occurs in chemical and biological settings; this ultimately led to the development of the McConnell Relation, which describes the distribution of electron spin in free radicals.

When Dr. McConnell moved to Stanford University in 1964, he began to use the methods of physical chemistry to study biological problems. There, he introduced a method called spin labels, in which electron and NMR spectra are used to study the structure and kinetics of proteins and lipids. His work showed how to measure the movement of molecules through and within membranes in the laboratory; this was later shown by many researchers to apply to living cell membranes. His research also showed how a protein present in the body combines with that of a foreign peptide on the cell membrane to enable the body to recognize a pathogenic invader.

Some of these discoveries are critical to understanding many properties of membranes, says Dr. McConnell, and a large portion of biology takes place in and on membranes, so understanding them is crucial.

Dr. McConnells recent work has focused on the behavior of cholesterol in membranes. Discoveries by his team concerning the properties of monomolecular films on the surface of water have shed light on cholesterol-phospholipid interactions that previously had puzzled scientists in several different fields of research.

Cholesterol forms special condensed complexes, says Dr. McConnell. By describing them mathematically, one can predict many of the properties that have been observed regarding cholesterol and phospholipid mixtures, which are major components of animal cell membranes. He believes th
'"/>

Contact: Melissa Quiroz
mquiroz@hillandknowlton.com
713-752-1916
The Welch Foundation
30-May-2002


Page: 1 2 3

Related biology news :

1. Harden McConnell named winner of 2002 Welch Award in Chemistry
2. Welch honors Kornberg for insights into DNA transcription
3. Welch Award honors 2 for unlocking natures secrets
4. Gladstone investigator Mike McCune wins prestigious NIH Directors Pioneer Award
5. UT Southwestern biochemist honored with NIH Directors Pioneer Award
6. Award winning researchers reveal potential new role for Glivec
7. UMaine anthropologist wins Solon T. Kimball Award
8. Secretary of Energy announces seven E.O. Lawrence Award Winners
9. Martin Saunders to receive the James Flack Norris Award
10. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
11. NJIT professor receives Presidential Award for breakthrough research with adult stem cells

Post Your Comments:
(Date:10/15/2014)... the 44th Rosenstiel Award for Distinguished Work in Biomedical ... the mechanisms of genomic instability and its implications for ... second alumnus to win the Rosenstiel Award; the first, ... Alt is the Charles A. Janeway Professor of Pediatrics ... an investigator at the Howard Hughes Medical Institute at ...
(Date:10/14/2014)... shows SIRT6—a protein known to inhibit the growth ... skin cancers by turning on an enzyme that increases ... Previously considered protective, SIRT6 is part of a family ... stability and prevent some of the genetic flaws associated ... lead to cancer. This study, in the journal,s October ...
(Date:10/14/2014)... of the planet,s leading questions is how to produce ... variable climate. The Food and Agriculture Organization of the ... over the next 40 years to feed a growing ... the necessary rise in food production. Plants—grains, cereals, ... supporting livestock. Current research must tap into our ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
(Date:10/22/2014)... YORK , Oct. 22, 2014 Nuvilex, ... Federation, approximately 400 million people worldwide are living with ... million people by 2030.  The global market for diabetes ... 2012 approximately 330,000 people worldwide died from pancreatic cancer.  ... death due to cancer in the United ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: